...
首页> 外文期刊>Annals of the Academy of Medicine, Singapore >Hyperbaric oxygen therapy for radiation-induced optic neuropathy.
【24h】

Hyperbaric oxygen therapy for radiation-induced optic neuropathy.

机译:高压氧疗法用于放射诱发的视神经病变。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Radiation-induced optic neuropathy (RON) is an infrequent but devastating consequence of radiation exposure to the visual pathways, usually following months to years after the treatment of paranasal or intracranial tumours. Hyperbaric oxygen (HBO) therapy is one of several therapies that have been tried for this condition. The purpose of this review is to describe the clinical characteristics of RON, the rationale for the use of HBO in this condition, and the available clinical data on its safety and efficacy. METHODS: MEDLINE searches were performed on radiation optic neuropathy, hyperbaric oxygen therapy, and similar terms, and selected references were reviewed. The results were combined with the experience at our own institution. RESULTS: RON typically follows a fulminant course with characteristic symptoms, examination findings, and imaging. The threshold for prior radiation exposure depends upon the delivery system used and patient characteristics. Therapy with anticoagulants or steroids has been unsuccessful. While there are case reports in the literature of successful treatment with HBO, therapy with HBO has to be initiated soon after the onset of vision loss, and even then yields variable results at best. CONCLUSIONS: There is still no consistently successful treatment for RON. HBO may be attempted in selected cases, but the prognosis for preservation of vision remains grim.
机译:简介:辐射诱发的视神经病变(RON)是辐射暴露于视觉通路的罕见但具有毁灭性的后果,通常是在鼻旁或颅内肿瘤治疗后数月至数年。高压氧(HBO)治疗是针对这种情况尝试的几种疗法之一。这篇综述的目的是描述RON的临床特征,在这种情况下使用HBO的原理以及关于其安全性和有效性的可用临床数据。方法:对放射线神经病变,高压氧治疗和类似术语进行MEDLINE搜索,并对所选参考文献进行回顾。结果与我们自己机构的经验相结合。结果:RON通常遵循特征性症状,检查结果和影像学的暴发性病程。先前辐射暴露的阈值取决于所使用的输送系统和患者特征。抗凝剂或类固醇的治疗一直没有成功。尽管在文献中有成功治疗HBO的病例报道,但必须在视力丧失发作后立即开始HBO治疗,即使这样,治疗效果也最好。结论:RON尚无持续成功的治疗方法。在某些情况下可能会尝试使用HBO,但保留视力的预后仍然严峻。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号